Montoro J, Balaguer RA, Sanz J. Recent advances in allogeneic transplantation for acute myeloid leukemia. Curr Opin Oncol. 2023;35:564–73.
Article CAS PubMed Google Scholar
Wang Y, Liu QF, Xu LP, Liu KY, Zhang XH, Ma X, et al. Haploidentical vs identical-siblingm transplant for AML in remission: a multicenter, prospective study. Blood. 2015;125:3956–62.
Article CAS PubMed Google Scholar
Bashey A, Zhang X, Sizemore CA, Manion K, Brown S, Holland HK, et al. T-cell-replete HLA-haploidentical hematopoietic transplantation for hematologic malignancies using post-transplantation cyclophosphamide results in outcomes equivalent to those of contemporaneous HLA-matched related and unrelated donor transplantation. J Clin Oncol. 2013;31:1310–6.
Article CAS PubMed Google Scholar
Huang XJ, Liu DH, Liu KY, Xu LP, Chen H, Han W, et al. Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies. Bone Marrow Transplant. 2006;38:291–7.
Chang YJ, Zhao XY, Huang XJ. Haploidentical stem cell transplantation for acute myeloid leukemia: current therapies, challenges and future prospective. Front Oncol. 2021;11:758512.
Article CAS PubMed Google Scholar
Bosch M, Dhadda M, Hoegh-Petersen M, Liu YP, Hagel LM, Podgorny P, et al. Immune reconstitution after antithymocyte globulin-conditioned hematopoietic cell transplantation. Cytotherapy. 2012;14:1258–75.
Article CAS PubMed Google Scholar
Wang Y, Liu DH, Liu KY, Xu LP, Zhang XH, Han W, et al. Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center. Cancer. 2013;119:978–85.
Zhou X, Lu X, Tang L, Yan H, Chen W, Shi W, et al. Optimization of ATG dose in haploid hematopoietic stem cell transplantation for hematologic malignancies. Chin J Hematol. 2020;41:557–63.
Oostenbrink LVE, Zijde CMJ, Kielsen K, Hoogendijk AMJ, Ifversen M, Müller KG, et al. Differential elimination of anti-thymocyte globulin of fresenius and genzyme impacts T-cell reconstitution after hematopoietic stem cell transplantation. Front Immunol. 2019;10:315.
Article CAS PubMed Google Scholar
Duftner C, Dejaco C, Hengster P, Bijuklic K, Joannidis M, Margreiter R, et al. Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells. PLoS ONE. 2012;7:e33939.
Article CAS PubMed Google Scholar
Leitner J, Pfistershammer KG, Majdic O, Zlabinger G, Steinberger P. Interaction of antithymocyte globulins with dendritic cell antigens. Am J Transplant. 2011;11:138–45.
Article CAS PubMed Google Scholar
Gérard S, Claudia S, Wolfgang AB, Hellmut DO, Matthias S, Axel RZ, et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood. 2011;117:6375–82.
Popow I, Leitner J, Grabmeier KP, Majdic O, Zlabinger GJ, Kundi M, et al. A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations. Am J Transplant. 2013;13:3103–13.
Article CAS PubMed Google Scholar
Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–238.
Article CAS PubMed Google Scholar
Martinelli G, Trabetti E, Farabegoli P, Testoni N, Bandini G, Motta MR, et al. Early detection of bone marrow engraftment by amplification of hypervariable DNA regions. Haematologica. 1997;82:156–60.
Thiede C, Bornhäuser M, Oelschlägel U, Brendel C, Leo R, Daxberger H, et al. Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia. 2001;15:293–302.
Article CAS PubMed Google Scholar
Jordan RC, Stuart DS, Andrea LJ, Helena L, Joanne M, Geoffrey IC, et al. Monitoring of chimerism following allogeneic hematopoietic stem cell transplantation (HSCT): technical recommendations for the use of short tandem repeat (STR) based techniques, on behalf of the United Kingdom National External Quality Assessment Service for Leucocyte Immunophenotyping Chimerism Working Group. Br J Haematol. 2015;168:26–37.
Przepiorka D, Weisdorf D, Martin P, Klingemann HG, Beatty P, Hows J, et al. 1994 Consensus Conference on acute GVHD grading. Bone Marrow Transplant. 1995;15:825–8.
Jagasia MH, Greinix HT, Arora M, Williams KM, Wolff D, Cowen EW, et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant. 2015;21:389–401.
Ephraim JF. Haploidentical transplantation for hematologic malignancies: where do we stand? Hematol Am Soc Hematol Educ Program. 2012;2012:230–6.
Reisner Y, Martelli MF, Gabutti V. Haploidentical hematopoietic stem cell transplantation: state of the art. Bone Marrow Transplant. 2011;46:159–66.
Lv M, Chang YJ, Huang XJ. Update of the “Beijing Protocol” haplo-identical hematopoietic stem cell transplantation. Bone Marrow Transplant. 2019;54:703–7.
Article CAS PubMed Google Scholar
Luznik L, O’Donnell PV, Fuchs EJ. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol. 2012;39:683–93.
Article CAS PubMed Google Scholar
Xu LP, Lu PH, Wu DP, Sun ZM, Liu QF, Han MZ, et al. Hematopoietic stem cell transplantation activity in China 2019: a report from the Chinese Blood and Marrow Transplantation Registry Group. Bone Marrow Transplant. 2021;56:2940–47.
Li XY, Yang J, Cai Y, Huang CM, Xu XW, Qiu HY, et al. Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study. Front Immunol. 2023;14:1252879.
Article CAS PubMed Google Scholar
Chang YJ, Huang XJ. Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience. Semin Hematol. 2016;53:82–9.
Article CAS PubMed Google Scholar
Huo MR, Pei XY, Li D, Chang YJ, Xu LP, Zhang XH, et al. Impact of HLA allele mismatch at HLA-A, -B, -C, -DRB1, and -DQB1 on outcomes in haploidentical stem cell transplantation. Bone Marrow Transplant. 2018;53:600–8.
Article CAS PubMed Google Scholar
Einsele H, Ljungman P, Boeckh M. How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation. Blood. 2020;135:1619–29.
Huang W, Yu L, Cao T, Li Y, Liu Z, Li H, et al. The efficacy and safety of rabbit anti-thymocyte globulin vs rabbit anti-T-lymphocyte globulin in peripheral blood stem cell transplantation from unrelated donors. Leuk Lymphoma. 2016;57:355–63.
Article CAS PubMed Google Scholar
Bergmann L, Fenchel K, Jahn B, Mitrou PS, Hoelzer D. Immunosuppressive effects and clinical response of fludarabine in refractory chronic lymphocytic leukemia. Ann Oncol. 1993;4:371–5.
Article CAS PubMed Google Scholar
Bredeson CN, Zhang MJ, Agovi MA, Bacigalupo A, Bahlis NJ, Ballen K, et al. Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide. Biol Blood Marrow Transplant. 2008;14:993–1003.
Article CAS PubMed Google Scholar
Koreth J, Matsuoka K, Kim HT, McDonough SM, Bindra B, Alyea EP, et al. Interleukin-2 and regulatory T cells in graft-versus-host disease. N Engl J Med. 2011;365:2055–66.
留言 (0)